TOKYO, March 21 - Craig Venter, Celera Genomics president and chief scientific officer, suggested Wednesday that Japan would play an increasingly significant role in the post-genomic age and indicated his interest in expanding his company’s presence in the country.

Terming the current phase the Golden Age of Discovery in proteomics, disease prevention, and medical treatment, Venter said that Japan “could end up leading the world in terms of the implementation of new ideas in medicine.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.